Return to study ST001660 main page

MB Sample ID: SA152066

Local Sample ID:20181008-ND2
Subject ID:SU001737
Subject Type:Cultured cells
Subject Species:Plasmodium falciparum
Taxonomy ID:5833
Genotype Strain:3D7
Gender:Not applicable
Cell Counts:1x10^8

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR001750
Treatment Summary:Plasmodium falciparum 3D7 parasites were cultured in RPMI 1640 medium and magnetically enriched to increase the infected to uninfected RBC ratio. Following hemocytometer counts, 1x10^8 parasites were measured per condition into 5 mL of total media for 2.5 hours in the presence of drug. No treatment or ND represents control parasites without additional alterations. Compounds (MMV...) are test compounds that were added at 10xIC50 value for the experimental duration. Blanks are sample tubes that follow the same procedures as samples following the quenching of metabolism. Both Pool and QC samples are combined samples of all samples from the analytical batch on that particular day. Dates in YYYYMMDD format are appended to individual samples to indicate the batch in which they were processed.
Treatment Protocol Filename:Metabolite_Extraction_for_LCMS_2017.pdf
Treatment Compound:MMV084978, MMV019721
Treatment Route:Transfer to media by pipette
Treatment Dose:10xIC50
Treatment Dosevolume:5 uL or less
Treatment Doseduration:2.5 hours
Treatment Vehicle:DMSO
Cell Storage:Temperature and gas composition controlled incubator
Cell Growth Container:6-well plate
Cell Growth Config:5 mL in each sample well, 1x10^8 infected red blood cells per well, conditions performed in triplicate
Cell Media:RPMI 1640 containing Albumax, Gentamycin, Hypoxanthine, HEPES, Sodium Bicarbonate
  logo